Combination of Dll4/Notch and Ephrin-B2/Ephb4 Targeted Therapy Is Highly Effective in Disrupting Tumor Angiogenesis
AuthID
P-003-0X7
P-003-0X7
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service